4,0
14 gen 2021
Dipendente anonimo
Dipendente attuale, più di un anno
Berlino
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Bayer's ambition is to remain a big, innovative player in the pharmaceutical industry. The company is currently going through a major transition by acquiring smaller, very promising biotech companies and divesting older business/products. This puts Bayer right on track and will strengthen the product pipeline/portfolio for the next years.
Svantaggi
Historically, Bayer is regarded as a very conservative company with "old", un-innovative men running the business. In part, this is still the case, even though I see constant improvement. Change needs time in a big company like Bayer